Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07752121
Recruiting
First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms
Not applicable · Germany · 1 site
Registry update: 4 Nov 2026
NCT07653685
Recruiting
A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.
Phase 1/2 · China · 31 sites
Registry update: 22 Sept 2026
NCT07747467
Recruiting
A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis
Phase 1 · United Kingdom · 1 site
Registry update: 28 Oct 2026
NCT07548476
Recruiting
Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy
Not applicable · United States · 1 site
Registry update: 26 Oct 2026
NCT07760454
Recruiting
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma
Phase 1/2 · China · 2 sites
Registry update: 17 Sept 2026
NCT07620275
Recruiting
Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA
Phase 1 · China · 3 sites
Registry update: 15 Sept 2026
NCT07747480
Recruiting
A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis
Phase 1 · United Kingdom · 1 site
Registry update: 5 Nov 2026
NCT07622706
Recruiting
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
Phase 2 · China · 1 site
Registry update: 27 Oct 2026
2026-525925-19-00
Recruiting
Randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety of Roluperidone in adults with negative symptoms of schizophrenia
Phase 3 · Bulgaria, Romania · 9 sites
Registry update: 10 Aug 2026
2025-523227-22-00
Recruiting
A Study for Comparing a Generic Combination of Brimonidine and Timolol Eye Drops versus Combigan® Eye Drops in the Treatment of Patients with Glaucoma
Phase 3 · Greece · 13 sites
Registry update: 27 Mar 2026
NCT07226713
Recruiting
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
Phase 2 · United States · 1 site
Registry update: 9 Sept 2026
NCT07764146
Recruiting
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
Phase 1 · United States · 2 sites
Registry update: 29 Oct 2026
NCT07830225
Recruiting
A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.
Not applicable · United States · 1 site
Registry update: 21 Sept 2026
2025-522000-24-00
Recruiting
A study of Mirdametinib in Infants and Toddlers under 24months of age with Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PNs)
Phase 1 · Germany, Spain · 4 sites
Registry update: 9 Oct 2026
NCT07746583
Recruiting
A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice
Not applicable · Hungary · 1 site
Registry update: 3 Nov 2026
2025-524283-38-00
Recruiting
HO182 CLL: Treatment of patients with chronic lymphocytic leukemia (CLL) with 6 cycles of rituximab in combination with 6 or 26 cycles of venetoclax upon recurrence of the disease after previous treatment
Phase 3 · Netherlands · 39 sites
Registry update: 28 Aug 2026
NCT07355335
Recruiting
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
Phase 1 · United States · 2 sites
Registry update: 8 Oct 2026
NCT07798388
Recruiting
Optimizing Gait Rehabilitation After Stroke
Not applicable · Belgium · 3 sites
Registry update: 21 Sept 2026
NCT07609719
Recruiting
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Phase 4 · Puerto Rico, United States · 8 sites
Registry update: 30 Oct 2026
NCT07784699
Recruiting
A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants
Phase 1 · China · 1 site
Registry update: 30 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.